Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Proteasome inhibitor.
Furan derivative.
Benzimidazole; microtubule polymerization inhib...
Smo inhibitor.
LBQ657 prodrug; neprilysin inhibitor.
Protease inhibitor.
Endogenous peptide, cleavage product of angiote...
Fermentation impurity
Protonophore; chitinase OvCHT1 inhibitor.
H+/K+ ATPase and ROCK-2 inhibitor.
Precursor in the synthesis of hydroquinone, ant...
Selective 5-HT6 receptor antagonist
Cysteine derivative found in Allium; NMDA NR2A/...
GnRH analog; GnRH1 agonist.
Retinoid, differentiation inducer.
PDGFR and c-Kit inhibitor.
Dihydropyridine; L-type and T-type Ca2+ channel...
Smac mimetic; IAP inhibitor.
α1-adrenergic agonist.
Imidazoquinoline nucleoside analog; TLR-7/8 ago...